Stephane Berghmans is a Doctor in Veterinary Medicine who obtained his Ph.D. in genetics and molecular biology at the University of Liege. He then became a postdoctoral fellow at Harvard Medical School where he established zebrafish as a cancer model at the Dana Farber Cancer Institute. He moved to the biotech sector in Cambridge (UK) in 2004 where he headed zebrafish drug discovery for early in vivo compound screening. He moved to Portland (Oregon, USA) in 2008 where he joined Znomics as Director of Biology. He joined the European Science Foundation in 2009 as Head of the Biomedical Sciences Unit, managing the secretariat general for the European Medical Research Councils (EMRC) with activities in science management, policy and strategy. Stephane joined Elsevier in 2013 as VP of Academic Relations in Brussels, responsible for relationships with research organisations and EU institutions. Since 2015 Stephane is a member of the EuroScience Governing Board.